
### [MONDO:0010613](http://purl.obolibrary.org/obo/MONDO_0010613)
**Label:** glycerol kinase deficiency

**Subclasses:** [MONDO:0018459](http://purl.obolibrary.org/obo/MONDO_0018459) (isolated glycerol kinase deficiency), [MONDO:0017295](http://purl.obolibrary.org/obo/MONDO_0017295) (glycerol kinase deficiency, juvenile form), [MONDO:0017294](http://purl.obolibrary.org/obo/MONDO_0017294) (glycerol kinase deficiency, infantile form), [MONDO:0010399](http://purl.obolibrary.org/obo/MONDO_0010399) (chromosome Xp21 deletion syndrome), [MONDO:0017296](http://purl.obolibrary.org/obo/MONDO_0017296) (glycerol kinase deficiency, adult form), 

**Corr. equiv. classes:** [Orphanet:284411](http://www.orpha.net/ORDO/Orphanet_284411), [Orphanet:261476](http://www.orpha.net/ORDO/Orphanet_261476), [Orphanet:408](http://www.orpha.net/ORDO/Orphanet_408), [Orphanet:284414](http://www.orpha.net/ORDO/Orphanet_284414), [Orphanet:284408](http://www.orpha.net/ORDO/Orphanet_284408), [OMIM:300679](http://purl.obolibrary.org/obo/OMIM_300679), 

**Class expressions from DL-Learner:**

- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0003330](http://purl.obolibrary.org/obo/HP_0003330) (Abnormal bone structure) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0000939](http://purl.obolibrary.org/obo/HP_0000939) (Osteoporosis) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 66.67%
- [HP:0000834](http://purl.obolibrary.org/obo/HP_0000834) (Abnormality of the adrenal glands) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) 66.67%


